March 5, 2020 / 12:23 PM / a month ago

BRIEF-EyePoint Pharmaceuticals Reports Q4 Loss Per Share Of $0.10

March 5 (Reuters) - EyePoint Pharmaceuticals Inc:

* EYEPOINT PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND HIGHLIGHTS RECENT CORPORATE PROGRESS

* Q4 REVENUE $8.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF $7.2 MILLION

* EYEPOINT PHARMACEUTICALS QTRLY LOSS PER SHARE OF $0.10

* EYEPOINT PHARMACEUTICALS - CASH AND CASH EQUIVALENTS AT DEC 31, 2019 TOTALED $22.2 MILLION COMPARED TO $31.8 MILLION AT SEPT 30, 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below